Oramed Pharmaceuticals Inc. (ORMP) Dropped -9.71% or -0.69 To Price $6.42 On Tuesday


Oramed Pharmaceuticals Inc. (ORMP) dropped -9.71% or -0.69 to $6.42. It is near 234576 shares traded, which is 877.77% compare to the average total volume 26724. The market cap of ORMP is $92.72 million. The year to date change is -31.92%. The 52 week price range is from $6.15 to $11.34. Price of ORMP have changed -4.82% during last week. It have changed -8.38% over last month, 11.62% over last 3 months, -22.21% over last 6 months and -7.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ORMP is 7.28. It is 13.40% above current price. The 200-day Moving Averages for ORMP is 8.27. It is 28.82% above current price. The 52-week High is 11.34. It is 76.64% from the current price. The 52-week Low is 6.15. It is -4.21% from current price.

There are some statistics of ORMP. It is has market cap $92.72 million. The share outstanding is 14.44 million. The average volume is 26724. The revenue is 1.23M. The gross profit is 1.23M. The percent of top 15 Institution holding is 1.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ORMP is -48.36%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ORMP is -25.24%.


Tags:

Share this post